Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Did you know? BPC 157 is a synthetic peptide being researched for its potential to support tissue repair, reduce inflammation, and stimulate angiogenesis, with multiple animal studies showing accelerated healing in muscles, tendons, BPC 157 Ligament: 1 Unsafe Truth Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #